Cord Blood America gains new customers with NeoCells acquisition
This article was originally published in Clinica
Stem cell preservation specialist Cord Blood America has bulked up its sample bank by acquiring ed the assets of NeoCells, a stem cell storage company and subsidiary of ViviCells International, for $320,000. The deal gives Cord Blood an extra 2,700 customers this year, and fits with the company's strategy to grow its gross margins by acquiring more patient samples.
You may also be interested in...
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.